Dr. Harin Haridas Kanani has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Harin Haridas Kanani, a member of the promoter group of Neogen Chemicals Limited, has filed a disclosure with the stock exchange under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires reporting of acquisitions made by promoters or promoter group entities in reliance on the exemption provisions under Regulation 10, which covers certain acquisitions that do not trigger the mandatory open offer requirement. The filing indicates a promoter group member has acquired additional shares of the company under one of these exempt categories. No specific number of shares or percentage acquired has been provided in the headline-level detail.
This is a routine compliance disclosure relating to a promoter group acquisition that qualified for an exemption from the open offer obligation. For retail investors, it signals incremental promoter buying activity but does not indicate a change in control or a large-scale stake change requiring a mandatory offer to all shareholders.